Search by Drug Name or NDC

    NDC 69230-0315-32 Maximum Strength Mucus Relief 1200 mg/1 Details

    Maximum Strength Mucus Relief 1200 mg/1

    Maximum Strength Mucus Relief is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Camber Consumer Care. The primary component is GUAIFENESIN.

    Product Information

    NDC 69230-0315
    Product ID 69230-315_bb6801c3-e110-4497-9dbd-b760ff99c255
    Associated GPIs 43200010007450
    GCN Sequence Number 063103
    GCN Sequence Number Description guaifenesin TAB ER 12H 1200 MG ORAL
    HIC3 B3J
    HIC3 Description EXPECTORANTS
    GCN 98863
    HICL Sequence Number 000271
    HICL Sequence Number Description GUAIFENESIN
    Brand/Generic Generic
    Proprietary Name Maximum Strength Mucus Relief
    Proprietary Name Suffix n/a
    Non-Proprietary Name Guaifenesin
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 1200
    Active Ingredient Units mg/1
    Substance Name GUAIFENESIN
    Labeler Name Camber Consumer Care
    Pharmaceutical Class Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209215
    Listing Certified Through 2023-12-31

    Package

    NDC 69230-0315-32 (69230031532)

    NDC Package Code 69230-315-32
    Billing NDC 69230031532
    Package 4 BLISTER PACK in 1 CARTON (69230-315-32) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2019-11-06
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.46903
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description MUCUS RELIEF ER 1,200 MG TAB
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 5d66abab-907f-404a-91ed-ec8f21721d68 Details

    Revised: 1/2022